Kenneth Samuel Hollander (Kenneth S Hollander)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 2

Top Topics

Tyrosine Kinase

Drug Administration

Metabolic Syndrome

Top Venues

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Naamit Deshet-Unger, Galit Horn, Moran Rawet-Slobodkin, Tova Waks, Ido Laskov, Nadav Michaan, Yael Raz, Vered Bar, Adi Zundelevich, Sara Aharon, Lubov Turovsky, Giuseppe Mallel, Seth Salpeter, Guy Neev, Kenneth Samuel Hollander, Ben-Zion Katz, Dan Grisaru, Anat Globerson Levin
Comparing Intraperitoneal and Intravenous Personalized ErbB2CAR-T for the Treatment of Epithelial Ovarian Cancer. Biomedicines 10 (9) (2022)
Amir Tirosh, Ediz S Calay, Gurol Tuncman, Kathryn C Claiborn, Karen E Inouye, Kosei Eguchi, Michael Alcala, Moran Rathaus, Kenneth Samuel Hollander, Idit Ron, Rinat Livne, Yoriko Heianza, Lu Qi, Iris Shai, Rajesh Garg, Gökhan S Hotamışlıgil
The short-chain fatty acid propionate increases glucagon and FABP4 production, impairing insulin action in mice and humans. Science translational medicine 11 (489) (2020)